By the three-stage study, we demonstrated that the positive rates of 14 IgG autoantibodies and 14 IgA autoantibodies in sera of IBS patients were significantly higher than HCs but had no significant difference with DCs. Here, CD79A is linked to irritable bowel syndrome.